Evrofarma SA Total Liabilities
Evrofarma SA total liabilities. Based on the latest financial reports, Evrofarma SA (EVROF) has total liabilities worth €34.79 Million EUR (≈ $40.67 Million USD) as of December 2022. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EVROF financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Evrofarma SA (2014–2022)
Total liabilities of Evrofarma SA from 2014 to 2022. This chart illustrates how Evrofarma SA's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Evrofarma SA to see how much of total assets are deployed in long-term investments.
Evrofarma SA Competitors by Total Liabilities
The table below lists competitors of Evrofarma SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV
|
USA | $16.70 Million |
|
Hannan Metals Ltd
V:HAN
|
Canada | CA$200.47K |
|
Decidr Ai Industries Ltd
AU:DAI
|
Australia | AU$17.13 Million |
|
Company K Partners Limited
KQ:307930
|
Korea | ₩5.40 Billion |
|
Consolidated Construction Consortium Limited
NSE:CCCL
|
India | Rs2.16 Billion |
|
Suprema ID Inc
KQ:317770
|
Korea | ₩31.52 Billion |
|
TsannKuen (China) Enterprise Co. Ltd
SHE:200512
|
China | HK$938.16 Million |
|
Pratama Widya Tbk Pt
JK:PTPW
|
Indonesia | Rp99.33 Billion |
Liability Composition Analysis (2014–2022)
This chart breaks down Evrofarma SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Evrofarma SA (EVROF) total assets.
Liquidity & Leverage Metrics
Evrofarma SA Total Liabilities Ratios Explained
Evrofarma SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.11 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Evrofarma SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Evrofarma SA (2014–2022)
The table below shows the annual total liabilities of Evrofarma SA from 2014 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | €34.79 Million ≈ $40.67 Million |
+2.57% |
| 2021-12-31 | €33.91 Million ≈ $39.65 Million |
+1.47% |
| 2020-12-31 | €33.42 Million ≈ $39.08 Million |
+13.96% |
| 2019-12-31 | €29.33 Million ≈ $34.29 Million |
-9.97% |
| 2018-12-31 | €32.58 Million ≈ $38.08 Million |
-5.21% |
| 2017-12-31 | €34.37 Million ≈ $40.18 Million |
+2.43% |
| 2016-12-31 | €33.55 Million ≈ $39.23 Million |
-2.90% |
| 2015-12-31 | €34.55 Million ≈ $40.40 Million |
-9.08% |
| 2014-12-31 | €38.00 Million ≈ $44.43 Million |
-- |
About Evrofarma SA
Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.